publicationMetadata:
  pmid: "18413802"
  title: "Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research â†’ antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    
    This is a laboratory research study investigating sorafenib treatment effects on MPNST cell lines.
    Expected tools include:
    - Cell lines (human tumor cell lines are explicitly mentioned)
    - Genetic reagents (siRNA mentioned for B-Raf and C-Raf depletion)
    - Potentially antibodies (for detecting phospho-proteins, cyclins, pRb)
    - Drug compounds (sorafenib as therapeutic agent)
    
    The study involves molecular biology techniques, cell culture, and protein analysis, making multiple
    tool types highly likely despite none being initially mined.
  overallAssessment: |
    This laboratory research study clearly uses multiple research tools including human tumor cell lines
    and siRNA reagents for functional studies. The publication describes experimental procedures involving
    cell culture, drug treatment, and molecular analysis that would require various research tools.
    Tools are expected and likely present but were missed during initial mining.

toolValidations: []

potentiallyMissedTools:
  - toolName: "MPNST cell line"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized"
    whyMissed: "Cell line name matches disease acronym (MPNST), may have been filtered out as disease reference"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "ST8814"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized"
    whyMissed: "Standard cell line nomenclature not captured by mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "LS141"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized"
    whyMissed: "Standard cell line nomenclature not captured by mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "DDLS"
    toolType: "cell_line"
    foundIn: "abstract"
    contextSnippet: "MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized"
    whyMissed: "Cell line acronym not recognized by mining patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "B-Raf siRNA"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "Small interfering RNA-mediated depletion of B-Raf in MPNSTs also induced a G(1) cell cycle arrest"
    whyMissed: "siRNA reagents not captured, may need specific patterns for 'siRNA-mediated depletion'"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "C-Raf siRNA"
    toolType: "genetic_reagent"
    foundIn: "results"
    contextSnippet: "whereas depletion of C-Raf did not affect either"
    whyMissed: "siRNA reagents not captured, implied from depletion context"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "sorafenib"
    toolType: "genetic_reagent"
    foundIn: "abstract"
    contextSnippet: "Tumor cells were treated with sorafenib and examined for growth inhibition"
    whyMissed: "Drug compounds may not be captured as genetic reagents, could be separate category"
    confidence: 0.85
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "context_phrase"
    pattern: "siRNA-mediated depletion of [GENE]"
    toolType: "genetic_reagent"
    examples: ["siRNA-mediated depletion of B-Raf", "depletion of C-Raf"]
    reasoning: "This phrase pattern reliably indicates use of siRNA reagents for gene knockdown experiments"

  - patternType: "context_phrase"
    pattern: "human tumor cell lines"
    toolType: "cell_line"
    examples: ["MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines"]
    reasoning: "Context phrase that indicates cell lines are being described, helps capture cell line names in parentheses"

  - patternType: "naming_convention"
    pattern: "[A-Z]{2,6}[0-9]{2,4}"
    toolType: "cell_line"
    examples: ["ST8814", "LS141", "DDLS"]
    reasoning: "Common cell line naming pattern with letters followed by numbers, would catch many standard cell lines"

  - patternType: "context_phrase"
    pattern: "treated with [COMPOUND]"
    toolType: "genetic_reagent"
    examples: ["treated with sorafenib"]
    reasoning: "Indicates experimental use of chemical compounds/drugs as research reagents"

  - patternType: "term"
    pattern: "small interfering RNA|siRNA"
    toolType: "genetic_reagent"
    examples: ["Small interfering RNA-mediated depletion"]
    reasoning: "Direct terms for siRNA reagents that are commonly used in functional studies"

observations:
  - resourceName: "MPNST cell line"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      MPNST cell lines were sensitive to sorafenib at nanomolar concentrations, showing growth inhibition.
      This sensitivity appeared to be due to inhibition of phospho-MEK and phospho-ERK, suppression of 
      cyclin D1, and hypophosphorylation of pRb at CDK4-specific sites, resulting in G1 cell cycle arrest.
    foundIn: "results"
    contextSnippet: "MPNSTs were sensitive to sorafenib at nanomolar concentrations. This appeared to be due to inhibition of p-MEK, p-ERK, suppression of cyclin D1, hypophosphorylation of pRb at the CDK4 specific sites, resulting in a G1 cell cycle arrest."
    confidence: 0.95
    doi: "10.1158/1535-7163.MCT-07-0518"

  - resourceName: "ST8814"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      ST8814 MPNST cell line showed sensitivity to sorafenib treatment with growth inhibition at 
      nanomolar concentrations, similar to the MPNST cell line, demonstrating consistent response
      across MPNST cell line models.
    foundIn: "results"
    contextSnippet: "MPNSTs were sensitive to sorafenib at nanomolar concentrations"
    confidence: 0.9
    doi: "10.1158/1535-7163.MCT-07-0518"

  - resourceName: "LS141"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      LS141 liposarcoma cell line did not show the same effects as MPNST cells when treated with sorafenib.
      These cells either did not express B-Raf or showed decreased Ras activation, explaining the lack
      of response to sorafenib treatment.
    foundIn: "results"
    contextSnippet: "These effects were not seen in the liposarcoma cells, which either did not express B-Raf or showed decreased Ras activation."
    confidence: 0.9
    doi: "10.1158/1535-7163.MCT-07-0518"

  - resourceName: "DDLS"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      DDLS dedifferentiated liposarcoma cell line did not respond to sorafenib treatment like MPNST cells.
      Similar to LS141, these cells either did not express B-Raf or showed decreased Ras activation,
      serving as a negative control for the MPNST-specific effects.
    foundIn: "results"
    contextSnippet: "These effects were not seen in the liposarcoma cells, which either did not express B-Raf or showed decreased Ras activation."
    confidence: 0.9
    doi: "10.1158/1535-7163.MCT-07-0518"

  - resourceName: "B-Raf siRNA"
    resourceType: "Genetic Reagent"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      siRNA-mediated depletion of B-Raf in MPNST cells induced G1 cell cycle arrest with marked 
      inhibition of cyclin D1 expression and Rb phosphorylation, phenocopying the effects of 
      sorafenib treatment and confirming B-Raf as the relevant target.
    foundIn: "results"
    contextSnippet: "SiRNA-mediated depletion of B-Raf in MPNSTs also induced a G1 cell cycle arrest in these cells, with a marked inhibition of cyclin D1 expression and Rb phosphorylation"
    confidence: 0.95
    doi: "10.1158/1535-7163.MCT-07-0518"

  - resourceName: "C-Raf siRNA"
    resourceType: "Genetic Reagent"
    observationType: "Cellular"
    observationTypeOntologyId: ""
    details: |
      siRNA-mediated depletion of C-Raf did not affect cell cycle progression or cyclin D1 expression
      and Rb phosphorylation in MPNST cells, demonstrating specificity for B-Raf in mediating the
      observed phenotypes and sorafenib sensitivity.
    foundIn: "results"
    contextSnippet: "whereas depletion of C-Raf did not affect either"
    confidence: 0.9
    doi: "10.1158/1535-7163.MCT-07-0518"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 7
  newPatternsCount: 5
  observationsExtracted: 6
  observationsByType:
    Cellular: 6
  majorIssuesFound: |
    - No tools were initially mined despite this being a clear laboratory research study
    - Multiple cell lines (MPNST, ST8814, LS141, DDLS) were completely missed
    - siRNA reagents for B-Raf and C-Raf depletion were not captured
    - Drug compound (sorafenib) used as research reagent was not identified
    - Mining patterns appear inadequate for capturing standard cell line nomenclature
    - Context phrases indicating tool usage ("treated with", "siRNA-mediated depletion") not recognized
  recommendations: |
    This publication demonstrates significant gaps in the current mining approach:
    
    1. All 7 potentially missed tools should be added - they represent genuine research tools used experimentally
    2. The 5 suggested patterns should be implemented to catch similar tools in future mining
    3. Cell line detection needs improvement, especially for:
       - Standard alphanumeric naming (ST8814, LS141)
       - Disease-related names that are also cell lines (MPNST)
       - Context phrases like "human tumor cell lines"
    4. siRNA reagent detection is completely missing and needs dedicated patterns
    5. Drug compounds used as research reagents should be considered for inclusion
    6. High-quality observations were extracted showing specific cellular phenotypes and drug responses
    7. This paper serves as an excellent test case for improving mining sensitivity while maintaining specificity
